Peter Bittermann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter bittermann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Bittermann Today - Breaking & Trending Today

Scarce doses and empty vaccination centres: Germany's vaccine rollout headache | WKZO | Everything Kalamazoo


By Caroline Copley and Annkathrin Weis
BERLIN/DILLENBURG, Germany (Reuters) - Proud of their national reputation for efficiency, Germans are growing increasingly frustrated by the slow rollout of a COVID-19 vaccine its scientists helped develop.
Scarce vaccine supply, cumbersome paperwork, a lack of healthcare staff and an aged and immobile population are hampering efforts to get early doses of a vaccine made by U.S.-based Pfizer and German partner BioNTech into the arms of the people.
Germany has set up hundreds of vaccination centres in sports halls and concert arenas and has the infrastructure to administer up to 300,000 shots a day, Health Minister Jens Spahn said. ....

United States , United Kingdom , Peter Bittermann , Lars Werthmann , Jan Harvey , Burkhard Ruppert , Nadine Schimroszik , Douglas Busvine , Caroline Copley , Annkathrin Weis , Bodo Ramelow , Emma Pinedo Gonzalez , Jens Spahn , European Union , Health Minister Jens Spahn , German Red Cross , Nicole Fey , New Year , German Red , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஜான் ஹார்வி , பர்கார்ட் ரூப்பர்ட் , கரோலின் கப்பலே , எம்மா பய்னெடோ கோன்சலஸ் , ஜென்ஸ் ஸ்பான் ,

Scarce doses and empty vaccination centres: Germany's vaccine rollout headache


6 Min Read
(In Jan 10 story, corrects paragraph 16 to say Pfizer and BioNTech halved 2020 output forecast in November, not December)
Germany starts by sending vaccination teams to care homes
Many vaccination centres stand idle
Lack of supply, burdensome paperwork slow mobile teams
Health minister targets 300,000 shots per day
As in U.S., Spain, performance varies between states
BERLIN/DILLENBURG, Germany, Jan 10 (Reuters) - Proud of their national reputation for efficiency, Germans are growing increasingly frustrated by the slow rollout of a COVID-19 vaccine its scientists helped develop.
Scarce vaccine supply, cumbersome paperwork, a lack of healthcare staff and an aged and immobile population are hampering efforts to get early doses of a vaccine made by U.S.-based Pfizer and German partner BioNTech into the arms of the people. ....

United States , United Kingdom , Peter Bittermann , Lars Werthmann , Jan Harvey , Burkhard Ruppert , Nadine Schimroszik , Douglas Busvine , Caroline Copley , Annkathrin Weis , Bodo Ramelow , Emma Pinedo Gonzalez , Jens Spahn , Thomson Reuters Trust Principles , European Union , Health Minister Jens Spahn , German Red Cross , Nicole Fey , New Year , German Red , Thomson Reuters Trust , Coronavirus Vaccines , Germany Corrected , Bio Therapeutic Drugs Trbc Level 5 , Central Eastern Europe , Company News ,